Clinical efficacy and safety of melatonin supplementation in multiple sclerosis: a systematic review

被引：14

作者：

Morsali, Soroush ^{[1
]}

Sabahi, Zahra ^{[2
]}

Kakaei, Javad ^{[3
]}

Hakimzadeh, Zahra ^{[4
]}

Hamidi, Sana ^{[1
]}

Gholipour-khalili, Elnaz ^{[5
]}

Sanaie, Sarvin ^{[4
]}

Talebi, Mahnaz ^{[4
]}

Naseri, Amirreza ^{[1
,2
]}

机构：

[1] Tabriz Univ Med Sci, Student Res Comm, Golgasht St, 5166-15731, Tabriz, E Azerbaijan, Iran

[2] Tabriz Univ Med Sci, Iranian EBM Ctr, Joanna Briggs Inst JBI Ctr Excellence, Res Ctr Evidence Based Med, Tabriz, Iran

[3] Islamic Azad Univ, Zanjan Branch IAUZ, Zanjan, Iran

[4] Tabriz Univ Med Sci, Neurosci Res Ctr NSRC, Tabriz 516615731, Iran

[5] Yeditepe Univ, Med Fac, Istanbul, Turkiye

来源：

INFLAMMOPHARMACOLOGY | 2023年 / 31卷 / 05期

关键词：

Multiple sclerosis; Melatonin; Systematic review; EXOGENOUS MELATONIN; OXIDATIVE STRESS; SLEEP DISORDERS; ANTIOXIDANT; IMPACT; MS;

D O I：

10.1007/s10787-023-01271-4

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

BackgroundMelatonin is a neurohormone secreted predominantly by the pineal gland that is demonstrated to be associated with the pathogenesis of multiple sclerosis (MS). This research desires to evaluate the tolerability and beneficial effects of exogenous melatonin supplementations in patients with MS.MethodsThis study was executed following the PRISMA 2020 statement. Both observational and interventional studies which reported the clinical effectiveness and/or safety of melatonin supplementation in patients with MS were included in this systematic review. Ovid, PubMed, Scopus, Embase, and Web of Science databases were searched and the risk of bias in included studies was assessed using the Joanna Briggs Institute (JBI) critical appraisal tools based on study design.ResultsOut of 1304 results of database searches, finally, 14 articles, including 7 randomized controlled trials (RCTs), 6 case-control studies, and one quasi-experimental study, were included based on the full-text review. Included phenotypes of MS were mostly relapsing-remitting MS (RRMS) (in 11 studies); it was secondary progressive MS (SPMS) in only one study, and two other studies had a mixture of the different phenotypes. The course of treatment with melatonin supplementation was between 2 weeks and 12 months. There were no substantial safety issues. Although melatonin was associated with enhanced oxidative stress and inflammation status, concerning the clinical benefits, limited studies suggested improvements in sleep conditions, cognitive outcomes, and fatigue in MS.DiscussionThere are insufficient data to support the regular melatonin prescription in MS. Limitations such as the small number of included studies, the diversity of the dosage, route, and duration of melatonin administration, and the diversity of assessment tests lead to unconvincing findings in this study. There is a need for future studies to achieve a comprehensive judgment on this subject.

引用

页码：2213 / 2220

页数：8

共 61 条

[21] Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis [J].

Ghareghani, Majid ;

Scavo, Linda ;

Arnoult, Damien ;

Zibara, Kazem ;

Farhadi, Naser .

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 (02) :181-187

[22] The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis [J].

Golan, Daniel ;

Staun-Ram, Elsebeth ;

Glass-Marmor, Lea ;

Lavi, Idit ;

Rozenberg, Orit ;

Dishon, Sara ;

Barak, Mira ;

Ish-Shalom, Sophia ;

Miller, Ariel .

BRAIN BEHAVIOR AND IMMUNITY, 2013, 32 :180-185

[23] Melatonin and multiple sclerosis [J].

Hawkes, Christopher H. ;

Baker, Mark D. ;

Pohl, Daniela ;

Lechner-Scott, Jeanette ;

Levy, Michael ;

Giovannoni, Gavin .

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 51

[24]

Hosseini S., 2022, J. Res. Clin. Med., V10, P23, DOI [10.34172/jrcm.2022.023, DOI 10.34172/JRCM.2022.023, 10.34172/jrcm.2022.023.-23, DOI 10.34172/JRCM.2022.023.-23]

[25] Effects of melatonin on sleep disturbances in multiple sclerosis: A randomized, controlled pilot study [J].